Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • PZWL
  • Reduced price

Churchill's In Clinical Practice Series: Diabetes and The Heart

9780443074691
124.00 zł
112.00 zł Save 12.00 zł Tax included
Lowest price within 30 days before promotion: 112.00 zł
Quantity
Product unavailable
Out of print

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
The In Clinical Practice series aims to provide expert information at your fingertips - concise handbooks organised in a straightforward way. Dr Barnett runs one of the largest diabetes clinics in the UK, and the book addresses the strong link between type II diabetes and cardiovascular disease. Cardiac disease is the leading cause of diabetes-related deaths, and the book includes discussions on the scale of the problem, co-occurrence of risk factors, and symptoms such as dyslipidaemia, hypertension and glycaemia. Also discussed is the importance of the metabolic or insulin-resistant syndrome. Key clinical trials are covered, and there are chapters on Treatment and Future Developments
.
Product Details
Churchill Livingstone
55662
9780443074691
9780443074691

Data sheet

Publication date
2003
Issue number
1
Cover
paperback
Pages count
128
Dimensions (mm)
210 x 280
Weight (g)
236
  • Introduction and background - scale of the problem of diabetes; reasons for exponential rise in numbers; overview of vascular complications.
    Definition and epidemiology - diabetes and cardiovascular disease focus on the heart scale of the problem
    Aetiology - importance of metabolic (insulin resistance) syndrome. Co-occurrence of risk factors for atherogenesis and vascular disease
    Obesity
    Lipids
    Hypertension
    Glycaemia
    Smoking
    Diagnosis - diabetes is a cardiovascular disease risk factor screening low threshold for investigations tools for investigation
    Prevention - evidence base for treatment key clinical trials
    Treatment - obesity, dyslipidaemia, hypertension, glycaemia, lifestyle advice
    Future developments - emphasis on care pathways algorithmic approaches treating to target new uses for established therapies (e.g. glitazones, rapid acting insulin secretagogues)
    Clinical cases
    Appendices
    References
    Index
Comments (0)

  • Frequently purchased together

    No products available